原文 | English |
---|---|
頁(從 - 到) | e129-e130 |
期刊 | Diabetes Care |
卷 | 45 |
發行號 | 9 |
DOIs |
|
出版狀態 | Published - 9月 2022 |
引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
於: Diabetes Care, 卷 45, 編號 9, 09.2022, p. e129-e130.
研究成果: Comment/debate
TY - JOUR
T1 - Sodium–Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease
T2 - A Nationwide Population-Based Cohort Study
AU - Chang, Hao Chih
AU - Kuo, Tzu Ting
AU - Chen, Yun Yu
AU - Lin, Yenn Jiang
AU - Chang, Hung Yu
AU - Hung, Chung Lieh
AU - Chung, Fa Po
N1 - Funding Information: The authors express their gratitude to the Taiwan Collaboration Centre of Health Information Application, Ministry of Health and Welfare, for providing the entire data set used for this study. Funding. This work was supported by the Ministry of Science and Technology (MOST 110-2314-B-A49A-541-MY3, MOST 109-2314-B-075-075-MY3, MOST 109-2314-B-010-058-MY2, MOST 109-2314-B-075-074-MY3, MOST 109-2314-B-075-076-MY3, MOST 107-2314-B-010-061-MY2, MOST 106-2314-B-075-006-MY3, MOST 106-2314-B-010-046-MY3, and MOST 106-2314-B-075-073-MY3), Research Foundation of Cardiovascular Medicine (110-02-006), Szu-Yuan Research Foundation of Internal Medicine, and Taipei Veterans General Hospital (V106C-158, V106C-104, V107C-060, V107C-054, V109C-113, V110C-116, V111C-159, VN111-05, V111C-128, C13-092, and C19-027). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the prep-aration, review, or approval of the manuscript. Funding Information: Acknowledgments. The authors express their gratitude to the Taiwan Collaboration Centre of Health Information Application, Ministry of Health and Welfare, for providing the entire data set used for this study. Funding. This work was supported by the Ministry of Science and Technology (MOST 110-2314-B-A49A-541-MY3, MOST 109-2314-B-075-075-MY3, MOST 109-2314-B-010-058-MY2, MOST 109-2314-B-075-074-MY3, MOST 109-2314-B-075-076-MY3, MOST 107-2314-B-010-061-MY2, MOST 106-2314-B-075-006-MY3, MOST 106-2314-B-010-046-MY3, and MOST 106-2314-B-075-073-MY3), Research Foundation of Cardiovascular Medicine (110-02-006), Szu-Yuan Research Foundation of Internal Medicine, and Taipei Veterans General Hospital (V106C-158, V106C-104, V107C-060, V107C-054, V109C-113, V110C-116, V111C-159, VN111-05, V111C-128, C13-092, and C19-027).
PY - 2022/9
Y1 - 2022/9
UR - http://www.scopus.com/inward/record.url?scp=85137136954&partnerID=8YFLogxK
U2 - 10.2337/dc22-0938
DO - 10.2337/dc22-0938
M3 - Comment/debate
C2 - 35838320
AN - SCOPUS:85137136954
SN - 0149-5992
VL - 45
SP - e129-e130
JO - Diabetes Care
JF - Diabetes Care
IS - 9
ER -